TrialJournal of negative results in biomedicine2013

A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma.

Kevin Murphy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.